首页|产后立即停药对妊娠期抗病毒治疗HBV感染孕妇ALT及病毒载量的影响

产后立即停药对妊娠期抗病毒治疗HBV感染孕妇ALT及病毒载量的影响

扫码查看
目的 探究妊娠期抗病毒治疗的慢性乙型肝炎病毒(HBV)感染孕妇分娩后立即停药对产后丙氨酸氨基转移酶(ALT)及HBV载量的影响,为临床提供参考.方法 纳入2017年2月-2022年2月在武汉市第三医院首义院区诊疗的150例HBV感染孕妇,根据患者孕期接受抗病毒治疗分娩后停药时间将其分为两组:A组(n=75)孕妇产后12周停药,B组(n=75)孕妇分娩后立即停药.记录两组孕妇分娩前至产后16周的HBV DNA载量变化,分娩前、分娩时及产后6个月的ALT水平,比较两组产后肝功能异常情况,并对可能影响产妇肝功能异常的因素进行分析.结果 分娩前、分娩时及产后16周,两组间的HBV DNA载量差异均无统计学意义(t=1.967、1.897、-0.985,P均>0.05);产后4、12周,B组的HBV DNA载量均高于A组,差异均有统计学意义(t=-41.994、-72.765,P均<0.001).两组分娩前、分娩时的ALT水平及产后6个月内ALT峰值水平比较差异均无统计学意义(t=0.928、0.866、-1.316,P均>0.05).两组产后肝功能异常率及异常程度比较差异均无统计学意义(Z/x2=0.176、0.348,P均>0.05),母婴阻断率均为100%.将28例产后发生肝功能异常的产妇纳入肝功异常组,其他122例纳入肝功正常组,两组在年龄、有无乙型肝炎家族史、有无分娩史、分娩方式、喂养方式、停药时间、是否早产等方面差异均无统计学意义(P均>0.05).结论 进行抗病毒治疗的HBV感染孕妇分娩后立即停药对产后ALT影响较小,会显著影响产后4、12周HBV DNA载量,但未对母婴阻断率造成影响.
Effect of immediate postpartum discontinuation of medication on ALT and viral load in pregnant women with HBV infection treated with antiviral therapy during pregnancy
Objective To explore the impact of stopping medication immediately after delivery on postpartum alanine aminotransferase(ALT)and hepatitis B virus(HBV)load in pregnant women with chronic HBV infection treated with antiviral therapy during pregnancy.Methods A total of 150 HBV-infected patients who underwent diagnosis and treatment in the Third Hospital of Wuhan from February 2017 to February 2022 were included in this study.Based on the time of discontinuation of antiviral treatment after delivery,the patients were divided into two groups:group A(n=75),who stopped the antiviral treatment 12 weeks after delivery,and group B(n=75),who stopped the antiviral treatment immediately after delivery.The changes in HBV DNA load before delivery and up to 16 weeks after delivery were recorded,and ALT levels were measured before delivery,during delivery,and at 6 months after delivery in both groups.The incidence of postpartum liver function abnormalities was compared between the two groups,and factors that might affect maternal liver function abnormalities were analyzed.Results There was no significant difference in HBV DNA levels between the two groups before delivery,during delivery,and 16 weeks postpartum(t=1.967,1.897,-0.985;all P>0.05).However,the HBV DNA levels of Group B were significantly higher than those of Group A at 4 and 12 weeks postpartum(t=-41.994,-72.765;all P<0.001).There was no significant difference in the levels of ALT before delivery,during delivery and peak ALT levels within 6 months postpartum between the two groups(t=0.928,0.866,-1.316;all P>0.05).There was no significant difference in the incidence and degree of postpartum liver function abnormality between the two groups(Z/x2=0.176,0.348;all P>0.05).The mother-to-child transmission rates were all 100%.Among the 28 postpartum women who had liver function abnormalities,122 other cases were included in the group with normal liver function;there was no significant difference between the two groups in terms of age,HBV family history,history of delivery,delivery mode,feeding method,discontinuation time,and premature delivery according to univariate analysis(all P>0.05).Conclusion In HBV infected pregnant women who received antiviral treatment immediately after delivery,the effect of drug withdrawal on postpartum ALT was small,and the HBV DNA load at 4 weeks and 12 weeks postpartum was significantly affected,and the mother-to-child blocking rate was not affected.

HBV infectionPregnant womenALTViral load

赵艳萍、赵轶男、贺群芳

展开 >

武汉市第三医院首义院区妇产科,湖北武汉 430000

慢性乙型肝炎病毒感染 孕妇 丙氨酸氨基转移酶 病毒载量

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(11)